IL-6 Inhibits Invasion in a Murine Model of Endometriosis

Area of Science:

• Gynecology
• Immunology
• Molecular Biology

Background:

• Endometriosis affects 10-15% of women, causing pain and infertility.
• Current treatments for endometriosis have limitations, including resistance and side effects.
• Interleukin-6 (IL-6) is a pro-inflammatory cytokine highly expressed in endometriosis.

Purpose of the Study:

• To investigate the role of IL-6 signaling in endometriosis pathophysiology.
• To evaluate the effect of an anti-IL-6 receptor (IL-6R) antibody on endometriosis progression in a mouse model.

Main Methods:

• Endometriosis was induced in C57BL/6 female mice.
• Mice were treated with a murine-specific anti-IL-6R antibody (15A7) or an IgG2b control.
• Lesion number, volume, attachment, and molecular signaling pathways (p38 MAPK, STAT3, N-Cadherin, ICAM) were analyzed.

Main Results:

• Anti-IL-6R treatment did not alter endometriosis lesion number or volume.
• Lesion attachment to the peritoneum significantly increased after anti-IL-6R antibody treatment.
• IL-6 signaling pathways (p38 MAPK, STAT3) were decreased, while N-Cadherin and ICAM remained unchanged.

Conclusions:

• IL-6 may play a paradoxical role in endometriosis, potentially limiting invasion and adhesion.
• Targeting IL-6R may not be a viable therapeutic strategy for reducing endometriosis progression.
• Further research is needed to elucidate the complex role of IL-6 in endometriosis pathophysiology.